デフォルト表紙
市場調査レポート
商品コード
988340

アレルギー免疫療法の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 108 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
アレルギー免疫療法の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2021年~2026年)
出版日: 2021年02月02日
発行: IMARC Services Private Limited
ページ情報: 英文 108 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー免疫療法の市場規模は、2020年に23億米ドルの価値に達し、2021年から2026年の間に10.50%のCAGRで拡大し、2026年までに41億米ドルに達すると予想されています。ました。脱感作または減感作とも呼ばれるアレルギー免疫療法は、さまざまな食品、薬、蜂毒、草花粉、イエダニなどのアレルゲンに対するアレルギー反応の予防的治療法です。アレルゲンの投与量を徐々に増やすことにより、免疫系の反応を変化させます。治療を開始する前に、アレルギー専門医と患者はアレルギー症状の引き金となる要因を分析します。これには、アレルゲンを確認するための皮膚検査と血液検査が含まれる場合があります。アレルギー免疫療法は、炎症を軽減し、長期的な影響を与え、免疫寛容を高め、病気の経過を変え、患者の生活の質を向上させるのに役立ちます。

近年、免疫系の機能に影響を与えるさまざまな環境要因やライフスタイル要因により、世界中でアレルギーの有病率が高まっています。アレルギー免疫療法への意識の高まり、所得の上昇、医療費の増加に伴い、最新の長期治療オプションに対する需要が高まっており、市場成長を促進する要因となっています。それは、世界中の政府組織と非政府組織の両方による臨床研究開発の予算増加でさらにサポートされています。また、最新の医薬品開発技術により、製薬会社は一連のアレルギーを効果的に治療するためのより効率的な免疫療法を生み出しました。これは、アレルギー診断の分野での進歩と相まって、世界のアレルギー免疫療法市場の成長を促進しています。

当レポートは世界のアレルギー免疫療法市場について調査しており、業界動向、市場予測、治療タイプ・アレルギータイプ・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のアレルギー免疫療法市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 治療タイプ別の市場セグメンテーション
  • アレルギータイプ別の市場セグメンテーション
  • 流通チャネル別の市場セグメンテーション
  • 地域別の市場セグメンテーション

第6章 治療タイプ別市場セグメンテーション

  • 皮下免疫療法(SCIT)
  • 舌下免疫療法(SLIT)

第7章 アレルギータイプ別市場セグメンテーション

  • アレルギー性鼻炎
  • 喘息
  • 食物アレルギー
  • 毒アレルギー
  • その他

第8章 流通チャネル別市場セグメンテーション

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 地域別市場セグメンテーション

  • 欧州
  • 北米
  • アジア太平洋地域
  • 中東・アフリカ
  • ラテンアメリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

  • 価格指標
  • 価格構造
  • 差益分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Stallergenes Greer
    • HAL Allergy Group
    • DBV Technologies
    • Merck Group
    • Aimmune Therapeutics
    • Circassia Pharmaceuticals
    • Anergis SA
    • Biomay AG
図表

List of Figures

  • Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
  • Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2020
  • Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2020
  • Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2020
  • Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
  • Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
  • Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2015 & 2020
  • Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2021-2026
  • Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2015 & 2020
  • Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2021-2026
  • Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2015 & 2020
  • Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2021-2026
  • Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
  • Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2021-2026
  • Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
  • Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Allergy Immunotherapies Market Structure
  • Table 7: Global: Allergy Immunotherapies Market: Key Players
目次
Product Code: SR1020A74_Report

The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth. Looking forward, IMARC Group expects the global allergy immunotherapies market to reach a value of US$ 4.10 Billion by 2026, exhibiting a CAGR of 10.50% during 2021-2026.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Market Breakup by Allergy Type:

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others
  • Market Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Market Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.

Key Questions Answered in This Report:

  • How has the global allergy immunotherapies market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global allergy immunotherapies industry?
  • What has been the impact of COVID-19 on the global allergy immunotherapies industry?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the allergy type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global allergy immunotherapies industry?
  • What are the key driving factors and challenges in the global allergy immunotherapies industry?
  • What is the structure of the global allergy immunotherapies industry and who are the key players?
  • What is the degree of competition in the global allergy immunotherapies industry?
  • What are the profit margins in the global allergy immunotherapies industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Treatment Type
  • 5.5 Market Breakup by Allergy Type
  • 5.6 Market Breakup by Distribution Channel
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Treatment Type

  • 6.1 Subcutaneous Immunotherapy (SCIT)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sublingual Immunotherapy (SLIT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

  • 7.1 Allergic Rhinitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Food Allergy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Venom Allergy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Europe
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 North America
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ALK-Abello A/S
    • 14.3.2 Allergy Therapeutics
    • 14.3.3 Stallergenes Greer
    • 14.3.4 HAL Allergy Group
    • 14.3.5 DBV Technologies
    • 14.3.6 Merck Group
    • 14.3.7 Aimmune Therapeutics
    • 14.3.8 Circassia Pharmaceuticals
    • 14.3.9 Anergis SA
    • 14.3.10 Biomay AG